versión imprimible
 
 

4th Annual Neuropsychiatric Drug Development Summit | September 28-30, 2021 | Digital

Evvnt Promotion / evvnt
-
28.09.2021 - 30.09.2021  Online
Time: 8:30 am - 5:00 pm
 
Temas de la conferencia
This last year has been a brutal reminder as to how crucial it is that we tackle the impending global mental health crisis and find a path towards successful neuropsychiatric drug development. We are proud to be the industry’s definitive and unrivalled forum focused on encapsulating the recent clinical advances across this extremely arduous field.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/791022-3?pid=4832

Speakers: Heather Dworak Senior Director, Clinical Research Sunovion, Daniel Mathalon Professor of Psychiatry and Behavioral Sciences UCSF Weill Institute for Neurosciences and more
 

Información e inscripción:

https://go.evvnt.com/791022-2?pid=4832
Mr. Customer Service
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Conference + 1 Workshop - Drug Developer: USD 2898.00, Conference Only - Drug Developer: USD 2399.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Swiss Tropical and Public Health InstituteHelix - Forschung & Beratung WienCenter of ExcellenceCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAGEM - Arbeitsgemeinschaft Ethnologie und MedizinEuropean Health Forum GasteinÖsterreichische Gesellschaft für Public Health